Analysis of colonies derived from single cells from patients with JAK2 and TET2 co-mutated MPN revealed differences in disease phenotype and response to targeted therapy that were dependent on the order of acquisition of these mutations.20 The gene discussed is JAK2; the disease is myeloproliferative disorder.